Walsh & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Walsh & Associates's LLY Position: Q3 2026 in Review
Walsh & Associates increased its Eli Lilly (LLY) stake by 16% in Q3 2026, buying an estimated $8.26K and bringing the position to 52 shares worth $60.2K. The position accounts for 0.05% of the portfolio, ranked #111.
Walsh & Associates first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Walsh & Associates held 52 shares of Eli Lilly worth $60.2K as of Q3 2026.
- Walsh & Associates bought 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
- Eli Lilly made up 0.05% of Walsh & Associates's portfolio in Q3 2026, its #111 holding.
- Walsh & Associates first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.